Assessing 48-Hour Efficacy of Double Dose Buprenorphine
This phase 1 study aims to identify the appropriate dose and evaluate the efficacy of a double dose of Buprenorphine over 48 hours, focusing on its impact on drug use, opioid agonist effects, opioid withdrawal, and pupil diameter.
Data Collection
Narcotic-Related Disorders+2
+ Mental Disorders
+ Opioid-Related Disorders
Treatment Study
Summary
Study start date: April 1, 1992
Actual date on which the first participant was enrolled.This study focuses on individuals who are on a daily maintenance dose of Buprenorphine, a medication used to treat opioid addiction. The main goal is to find out if taking two times the usual daily dose every other day can still provide the same effects for a full 48 hours. This research is important as it could potentially simplify treatment plans and improve the quality of life for those managing opioid dependence.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 28 to 45 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Please contact site for information.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location